These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 515037)

  • 21. [Cytosol monoamine oxidase in the rat liver].
    Moskvitina TA; Medvedev AE
    Vopr Med Khim; 2000; 46(1):48-51. PubMed ID: 10802886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular and kinetic characterization of monoamine oxidases in the rat heart.
    Guimarães JT; Vindis C; Soares-da-Silva P; Parini A
    Biochem Soc Trans; 1998 Nov; 26(4):S392. PubMed ID: 10047906
    [No Abstract]   [Full Text] [Related]  

  • 23. Rat brain monoamine oxidase inhibition by beta-diethylaminoethyl diphenylprophylacetate (SKF-525A).
    Pfeffer M; Semmel M; Schor JM
    Enzymologia; 1968 Jul; 34(5):299-303. PubMed ID: 5672567
    [No Abstract]   [Full Text] [Related]  

  • 24. Bioactive contaminants leach from disposable laboratory plasticware.
    McDonald GR; Hudson AL; Dunn SM; You H; Baker GB; Whittal RM; Martin JW; Jha A; Edmondson DE; Holt A
    Science; 2008 Nov; 322(5903):917. PubMed ID: 18988846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. D-amphetamine and DL-alpha-N-methyltryptamine eliminate the irreversible inhibition of mitochondrial monoamine oxidase, caused by clorgyline. The specific action on the tyramine oxidation.
    Severina IS
    Biochem Int; 1984 Aug; 9(2):219-28. PubMed ID: 6487343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antagonism between stereoisomeric amphetamines, amphetamine derivatives and other monoamine oxidase inhibitors.
    Parmar SS
    Biochem Pharmacol; 1966 Oct; 15(10):1497-505. PubMed ID: 4382014
    [No Abstract]   [Full Text] [Related]  

  • 27. The role of brain norepinephrine in the anorexic effects of dextroamphetamine and monoamine oxidase inhibitors in the rat.
    Holtzman SG; Jewett RE
    Psychopharmacologia; 1971; 22(2):151-61. PubMed ID: 5124188
    [No Abstract]   [Full Text] [Related]  

  • 28. The effects of thyroid hormones on monoamine oxidase in the rat heart.
    Lyles GA; Callingham BA
    J Pharm Pharmacol; 1974 Dec; 26(12):921-30. PubMed ID: 4156856
    [No Abstract]   [Full Text] [Related]  

  • 29. Catechol-O-methyl transferase and monoamine oxidase activities in the heart and liver of the embryonic and developing chick.
    Ignarro LJ; Shideman FE
    J Pharmacol Exp Ther; 1968 Jan; 159(1):29-37. PubMed ID: 5643948
    [No Abstract]   [Full Text] [Related]  

  • 30. [Deamination disorders of some nitrogen compounds and means for their normalization in experimental conditions].
    Gorkin VZ; Akopian ZhI; Kulygina AA; Zeĭnalov TA
    Biull Eksp Biol Med; 1971 Nov; 72(11):42-5. PubMed ID: 5131033
    [No Abstract]   [Full Text] [Related]  

  • 31. The relative effects of d-amphetamine, imipramine and harmaline on tetrabenazine suppression of schedule-controlled behavior in the rat.
    McKearney JW
    J Pharmacol Exp Ther; 1968 Feb; 159(2):429-40. PubMed ID: 5638662
    [No Abstract]   [Full Text] [Related]  

  • 32. Unusual pattern of beta-phenylethylamine deamination in the rat heart.
    Guimarães JT; Soares-Da-Silva P
    Biochem Soc Trans; 1997 Nov; 25(4):S622. PubMed ID: 9450050
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of chloracizin on activity of mitochondrial monoamine oxidase.
    Vikhlyaev YI; Gorkin VZ; Gridneva LI; Smirnova AV
    Fed Proc Transl Suppl; 1965; 24(6):1127-30. PubMed ID: 5215185
    [No Abstract]   [Full Text] [Related]  

  • 34. [Mechanism of action of adrenaline and some other biogenic amines on gamma-amylase activity of rat liver and heart muscle].
    Orlova VS; Siniukhin VN; Popova IA; Gorkin VZ; Rozenfel'd EL
    Biokhimiia; 1971; 36(3):555-61. PubMed ID: 5132486
    [No Abstract]   [Full Text] [Related]  

  • 35. [Properties of monoamine oxidases from myocardial mitochondria].
    Krivchenkova RS; Brusova EG
    Vopr Med Khim; 1977; (6):834-40. PubMed ID: 595488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [INTERFERENCE BY D-AMPHETAMINE IN THE ACTION OF SOME MONOAMINE OXIDASE INHIBITORS].
    FERRI S; MAFFEI-FACCIOLI A; ORNESI A; SCAMAZZO T
    Boll Soc Ital Biol Sper; 1963 Nov; 39():1381-4. PubMed ID: 14123621
    [No Abstract]   [Full Text] [Related]  

  • 37. [Inhibition of monoamine oxidase by bacteriostatically active nitrofuran derivatives].
    Palm D; Magnus U; Grobecker H; Jonsson J
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 256(2):281-300. PubMed ID: 4233003
    [No Abstract]   [Full Text] [Related]  

  • 38. The influence of age on the recovery of cardiac monoamine oxidase after irreversible inhibition.
    Horita A
    Biochem Pharmacol; 1968 Oct; 17(10):2091-6. PubMed ID: 5696878
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of imipramine, desipramine and monoamine oxidase inhibitors on the metabolism and psychomotor stimulant actions of d-amphetamine in mice.
    Lew C; Iversen SD; Iversen LL
    Eur J Pharmacol; 1971 May; 14(4):351-9. PubMed ID: 4400534
    [No Abstract]   [Full Text] [Related]  

  • 40. Induced appearance of adenylate-deaminating activity in highly purified bovine liver mitochondrial monoamine oxidase.
    Akopyan ZI; Kulygina AA; Terzeman II; Gorkin VZ
    Biochim Biophys Acta; 1972 Nov; 289(1):44-56. PubMed ID: 4538982
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.